Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes
Mohammad A. I. Al-Hatamleh, Ma’mon M. Hatmal, Walhan Alshaer, et al.
European Journal of Pharmacology (2021) Vol. 896, pp. 173930-173930
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects
Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin N. Olaimat, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 556-556
Open Access | Times Cited: 199
Reported Adverse Effects and Attitudes among Arab Populations Following COVID-19 Vaccination: A Large-Scale Multinational Study Implementing Machine Learning Tools in Predicting Post-Vaccination Adverse Effects Based on Predisposing Factors
Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin N. Olaimat, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 366-366
Open Access | Times Cited: 61
Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine
Rebecca Tan, Pouya Hassandarvish, Chin Fei Chee, et al.
Carbohydrate Polymers (2022) Vol. 290, pp. 119500-119500
Open Access | Times Cited: 35
Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Foods (2022) Vol. 11, Iss. 18, pp. 2884-2884
Open Access | Times Cited: 35
Quality by Design Approach in Liposomal Formulations: Robust Product Development
Walhan Alshaer, Hamdi Nsairat, Zainab Lafi, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 10-10
Open Access | Times Cited: 33
Ultrasensitive Detection of COVID-19 Causative Virus (SARS-CoV-2) Spike Protein Using Laser Induced Graphene Field-Effect Transistor
Tianrui Cui, Yancong Qiao, Jianwei Gao, et al.
Molecules (2021) Vol. 26, Iss. 22, pp. 6947-6947
Open Access | Times Cited: 39
Recent Developments in Oral Delivery of Vaccines Using Nanocarriers
Amna Zafar, Raffia Arshad, Asim ur Rehman, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 490-490
Open Access | Times Cited: 14
The application of nanomedicine in clinical settings
Qingsong Zhao, Cheng Nuo, Xuyan Sun, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 14
Lessons from the history of inorganic nanoparticles for inhalable diagnostics and therapeutics
Vuk Uskoković
Advances in Colloid and Interface Science (2023) Vol. 315, pp. 102903-102903
Open Access | Times Cited: 12
Nanostructures for the Prevention, Diagnosis, and Treatment of SARS-CoV-2: A Review
N. Burak Kiremitler, Munteha Zeynep Kemerli, Nilgün Kayacı, et al.
ACS Applied Nano Materials (2022) Vol. 5, Iss. 5, pp. 6029-6054
Open Access | Times Cited: 16
Gold Nanoparticle-Decorated Polymer Particles for High-Optical-Density Immunoassay Probes
Hiroshi Yabu, Seiji Yokokura, Seiichi Shimizu
Langmuir (2024) Vol. 40, Iss. 6, pp. 3268-3273
Closed Access | Times Cited: 3
Evaluation of Short-Term Side Effects Following the First Dose of COVID-19 Vaccines Among Physicians and Dentists: A Cross-Sectional Study from India
Md Anwarul Azim Majumder, Keerti Singh, WMS Johnson, et al.
Journal of Multidisciplinary Healthcare (2023) Vol. Volume 16, pp. 161-174
Open Access | Times Cited: 8
Systematic review of the effects of environmental factors on virus inactivation: implications for coronavirus disease 2019
Lei Guo, Zhi‐gang Yang, L. Zhang, et al.
International Journal of Environmental Science and Technology (2021) Vol. 18, Iss. 9, pp. 2865-2878
Open Access | Times Cited: 17
Engineered liposomes to deliver nucleic acid mimics in Escherichia coli
Luis Fernando Moreira, Nuno Guimarães, Sara Pereira, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 489-500
Open Access | Times Cited: 6
Knowledge, perception, and fear among the global population towards newly evoked variant Omicron (B.1.1.529)
Ali Qureshi, Syed Azhar Syed Sulaiman, Narendar Kumar, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0270761-e0270761
Open Access | Times Cited: 7
The Role of Nanomedicine in COVID-19 Therapeutics
Smriti Sharma
Nanomedicine (2022) Vol. 17, Iss. 3, pp. 133-136
Open Access | Times Cited: 6
Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm
Mai Abdel Haleem Abusalah, Moad Khalifa, Mohammad A. I. Al-Hatamleh, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 3, pp. 386-386
Open Access | Times Cited: 6
A review of metallic nanostructures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Istuti Saraswat, Sarmistha Saha, Anuja Mishra
Toxicology and Environmental Health Sciences (2023) Vol. 15, Iss. 4, pp. 315-324
Closed Access | Times Cited: 3
Recent Advancement of Polymersomes as Drug Delivery Carrier
Kuldeep Singh, Avadh Biharee, Amber Vyas, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 20, pp. 1621-1631
Closed Access | Times Cited: 4
Application of Nanotechnology in COVID-19 Infection: Findings and Limitations
Ibrahim Aminu Shehu, Muhammad Kabir Musa, Aparna Datta, et al.
Journal of Nanotheranostics (2022) Vol. 3, Iss. 4, pp. 203-232
Open Access | Times Cited: 4
Common Side Effects of COVID-19 Vaccines Used in Iran: A Review
Sepehr Siahvoshi, Emad Movahed, Kimia Ghods
Annals of Military and Health Sciences Research (2022) Vol. 19, Iss. 4
Open Access | Times Cited: 3
Knowledge, Attitudes, and Perceptions towards COVID-19 Disease and Vaccinations: A Cross-sectional Study from a Developing Country
Majd M. Masadeh, Nasr Alrabadi, Sabariah Noor Harun
The Open Public Health Journal (2024) Vol. 17, Iss. 1
Open Access
Polymersomes as Next Generation Nanocarriers for Drug Delivery: Recent Advances, Patents, Synthesis and Characterization
Surya Goel, Ruchi Singh, Megha Tonk
Current Nanoscience (2023) Vol. 20, Iss. 6, pp. 753-768
Closed Access | Times Cited: 1
A Glance on Nanovaccine: A Potential Approach for Disease Prevention
Akash Garg, Rutvi Agrawal, Himansu Chopra, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 11, pp. 1406-1418
Closed Access
LEAF- 4L6715 enhances oxygenation in patients with acute respiratory distress syndrome (ARDS) due to severe COVID-19: Final results of a phase I/II clinical trial
Paul‐Michel Mertès, Xavier Delabranche, Pierre Coliat, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1 - Next Page

Scroll to top